Prognostic value of systemic inflammation in patients undergoing 1st-line chemotherapy for metastatic pancreatic cancer: Tokushukai REAl-world Data project

被引：0
|
作者：
Shimoyama, Rai [1 ]
Imamura, Yoshinori [2 ]
Uryu, Kiyoaki [3 ]
Mase, Takahiro [4 ]
Fujimura, Yoshiaki [5 ]
Hayashi, Maki [6 ]
Ohtaki, Megu [7 ]
Ohtani, Keiko [7 ]
Shinozaki, Nobuaki [1 ,8 ]
Minami, Hironobu [2 ]
机构：
[1] Shonankamakura Gen Hosp, Dept Gen Surg, Kamakura, Kanagawa, Japan
[2] Kobe Univ, Grad Sch Med, Dept Med Oncol & Hematol, Kobe, Hyogo, Japan
[3] Yao Tokushukai Hosp, Dept Resp Med & Oncol, Yao, Japan
[4] Ogaki Tokushukai Hosp, Dept Breast Surg, Ogaki, Japan
[5] Tokushukai Informat Syst Inc, Osaka, Japan
[6] Irai Iryo Res Ctr Inc, Kashiwa, Chiba, Japan
[7] deCult Co Ltd, Kurashiki, Okayama, Japan
[8] Gen Inc Assoc Tokushukai, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.340
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P10-2
引用
收藏
页码：S1445 / S1446
页数：2
相关论文
共 50 条
  • [41] Clinical outcomes and prognostic factors in recurrent and/or metastatic head and neck cancer patients treated with chemotherapy plus cetuximab as first-line therapy in a real-world setting
    Depenni, Roberta
    Rocca, Maria Cossu
    Ferrari, Daris
    Azzarello, Giuseppe
    Baldessari, Cinzia
    Alu, Massimiliano
    Nole, Franco
    Codeca, Carla
    Boscolo, Giorgia
    Piccininni, Marco
    Cavalieri, Stefano
    Bossi, Paolo
    EUROPEAN JOURNAL OF CANCER, 2019, 115 : 4 - 12
  • [42] Later lines of systemic therapy in patients with metastatic colorectal cancer: real-world data from a setting with barriers to access cancer therapies
    Jacome, Alexandre A.
    Mathias-Machado, Maria Cecilia
    Gil, Mariana
    Passarini, Thais M.
    Cristofaro, Sabrina
    Moraes, Eduardo D.
    Freitas, Laura V. W.
    Prolla, Gabriel
    Amorim, Larissa C.
    Paes, Rafael D.
    Gasparotto, Bianca
    Canedo, Jorge
    Ferreira, Carlos Gil
    Ferrari, Bruno
    Garicochea, Bernardo
    Gil, Roberto
    Peixoto, Renata D'Alpino
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (06)
  • [43] Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
    Wu, Chiao-En
    Chou, Wen-Chi
    Hsieh, Chia-Hsun
    Chang, John Wen-Cheng
    Lin, Cheng-Yu
    Yeh, Chun-Nan
    Chen, Jen-Shi
    BMC CANCER, 2020, 20 (01)
  • [44] Prognostic and predictive factors for Taiwanese patients with advanced biliary tract cancer undergoing frontline chemotherapy with gemcitabine and cisplatin: a real-world experience
    Chiao-En Wu
    Wen-Chi Chou
    Chia-Hsun Hsieh
    John Wen-Cheng Chang
    Cheng-Yu Lin
    Chun-Nan Yeh
    Jen-Shi Chen
    BMC Cancer, 20
  • [45] Treatment patterns and outcomes of patients with metastatic colorectal cancer in third-line and beyond systemic therapy: Real-world data from a setting with limited resources
    Jacome, Alexandre A.
    Gil, Roberto Almeida
    de Moraes, Eduardo Dias
    Peixoto, Renata D'Alpino
    Canedo, Jorge Alexandre
    Passarini, Thais
    Gil, Mariana
    Pereira, Sabrina
    Amorim, Larissa
    Prolla, Gabriel
    Freitas, Laura
    Coelho, Fernanda
    Paiva, Isabela
    Paes, Rafael
    Cruz, Heloisa
    Costa e Silva, Matheus
    Ferreira, Carlos Gil
    Ferrari, Bruno Lemos
    Garicochea, Bernardo
    Dienstmann, Rodrigo
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)
  • [46] Pembrolizumab in Combination with Chemotherapy for Patients with metastatic NSCLC: An Analysis using Real-World Data from the National Clinical Cancer Registry
    Haberlin, J.
    Kanz, F.
    Surovtsova, I
    Morakis, P.
    PNEUMOLOGIE, 2024, 78 : S100 - S101
  • [47] Prediction of overall survival for metastatic pancreatic cancer: Development and validation of a prognostic nomogram with data from open clinical trial and real-world study
    Hang, Junjie
    Wu, Lixia
    Zhu, Lina
    Sun, Zhiqiang
    Wang, Ge
    Pan, Jingjing
    Zheng, Suhua
    Xu, Kequn
    Du, Jiadi
    Jiang, Hua
    CANCER MEDICINE, 2018, 7 (07): : 2974 - 2984
  • [48] Disease control with prior platinum-based chemotherapy is prognostic for survival in patients with metastatic urothelial cancer treated with atezolizumab in real-world practice
    Mencinger, Marina
    Mangaroski, Dusan
    Bokal, Urska
    RADIOLOGY AND ONCOLOGY, 2021, 55 (04) : 491 - 498
  • [49] CA19-9 Response to 1st-Line Neoadjuvant FOLFIRINOX and 2nd-Line Gemcitabine-Based Chemotherapy in Patients with Operable Pancreatic Cancer
    Thalji, S.
    Kamgar, M.
    George, B.
    Aldakkak, M.
    Christians, K.
    Clarke, C. N.
    Erickson, B.
    Hall, W.
    Tolat, P.
    Khan, A.
    Evans, D. B.
    Tsai, S.
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 1) : S20 - S20
  • [50] Comparison of real-world mortality data among patients with glioblastoma (GBM) and metastatic pancreatic cancer (mPC) treated in the community oncology setting
    Cosgrove, David
    Aguilar, Kathleen
    Wang, Yunfei
    Sykes, Charles
    Reinwald, Sarah
    Kubisiak, Emily
    Su, Zhaohui
    Chandrasekaran, Vasu
    Stees, Larisa
    Iyer, Rupa
    Robert, Nicholas J.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345